RHOA and liver cancer: Wu [78] found through network pharmacological analysis that the YQJPJD formula mainly regulates potential therapeutic targets of liver cancer through key ingredients such as luteolin, quercetin and baicalin and exerts anti-liver cancer effects through core targets such as RAC1, MAPK3, and RHOA.